• Surface Adsorption and Antimicrobial Efficacy of Hexetidine

  2026-04-21

  This pivotal study investigates how surface adsorption and staining reactions influence the antimicrobial activity of cationic antiseptic mouthwashes, including Hexetidine, against key oral pathogens. The findings clarify the unique behavior of Hexetidine compared with other agents and highlight implications for assay design and clinical translation.

• Trichostatin A (TSA) for Epigenetic Regulation in Cancer Res

  2026-04-20

  Harness the precision of Trichostatin A (TSA) to dissect epigenetic regulation in cancer, with a focus on cell cycle control and translational oncology. This guide integrates advanced workflows, evidence-backed troubleshooting, and actionable insights from recent breakthroughs, empowering researchers to maximize TSA's impact in complex experimental systems.

• Single-Nucleus RNA-Seq Reveals ATRNL1's Role in Atrial Fibri

  2026-04-20

  This study by Hill et al. provides the first large-scale, cell-type-resolved transcriptional map of human atrial fibrillation (AF), identifying ATRNL1 as a key regulatory gene in cardiomyocytes. The findings offer new molecular targets for AF research and highlight the power of single-nucleus RNA sequencing in unraveling disease mechanisms.

• Angiotensin 1/2 (2-7): Reliable Solutions for Cell-Based Ass

  2026-04-19

  This article addresses recurring laboratory challenges in cell viability and proliferation assays by leveraging the validated performance of Angiotensin 1/2 (2-7) (SKU A1050). Drawing on peer-reviewed research and practical optimization data, it demonstrates how this high-purity, robustly soluble peptide fragment enables reproducible, quantitative results in both cardiovascular and viral pathogenesis models. Biomedical researchers will find actionable protocol guidance and evidence-driven vendor comparisons to streamline experimental workflows.

• E-64d: Precision Cysteine Protease Inhibition in Cell Death

  2026-04-18

  E-64d, a membrane-permeable cysteine protease inhibitor, enables robust, selective interrogation of calpain and cathepsin-driven cell death pathways within complex biological systems. By integrating insights from recent lysoptosis research and best-practice workflows, this article empowers scientists to overcome common pitfalls and optimize experimental reproducibility using APExBIO’s E-64d.

• Lycopene Mitigates DON-Induced Intestinal Barrier Dysfunctio

  2026-04-17

  This study demonstrates that lycopene counteracts deoxynivalenol (DON)-induced intestinal barrier damage and NLRP3 inflammasome activation in IPEC-J2 cells by targeting the ERK pathway. These findings clarify the molecular mechanisms of lycopene's protective effects and inform future strategies for mitigating mycotoxin-related enterotoxicity.

• Rapakinin-Induced Vasorelaxation: Mechanisms Beyond NO Pathw

  2026-04-16

  This study identifies rapakinin, a peptide from rapeseed protein, as a novel endothelium-dependent vasodilator in spontaneously hypertensive rats. Unlike classic ACE inhibitors, rapakinin’s antihypertensive effect is mediated primarily via the prostaglandin I2 (PGI2) IP receptor and downstream cholecystokinin CCK1 receptor signaling, rather than nitric oxide synthase inhibition.

• Epigenetic Regulation Predicts FGFR Inhibitor Sensitivity in

  2026-04-15

  Bao et al. (2021) reveal that DNA methylation patterns in FGFRs, FGFs, and CCND1 modulate gene expression and associate with sensitivity to the selective FGFR inhibitor PD 173074 in head and neck squamous cell carcinoma (HNSCC). This integrative epigenetic analysis highlights the potential of DNA methylation as a predictive biomarker for targeted therapy response.

• Verapamil HCl in Drug Resistance: Mechanistic Insights for M

  2026-04-14

  Explore Verapamil HCl as an L-type calcium channel blocker with a unique focus on its role in intracellular drug accumulation and resistance modulation in myeloma and arthritis research. Uncover new scientific perspectives beyond standard apoptosis and inflammation pathways.

• Patient-Derived 3D Spheroid Models for Prostate Cancer Resea

  2026-04-13

  This study establishes and characterizes patient-derived 3D spheroid cultures from radical prostatectomy specimens, providing a more physiologically relevant in vitro model for organ-confined prostate cancer. The model enables robust drug response studies and better representation of tumor heterogeneity, addressing limitations of conventional cell lines.

• Fluo-4 AM: Unleashing the Next Era of Calcium Imaging Innova

  2026-04-12

  This thought-leadership article explores how Fluo-4 AM, a fluorescent calcium indicator from APExBIO, is redefining translational research by enabling high-sensitivity, real-time intracellular calcium measurements. We synthesize mechanistic insights, recent bioelectronic breakthroughs, and practical guidance for researchers seeking to bridge cell signaling assays with next-generation biomedical applications such as artificial retinal prostheses. Evidence from state-of-the-art studies and best-practice protocols is critically integrated to offer a strategic, future-facing perspective.

• CAFs-Derived Fatty Acids Promote Oral Cancer via Lipid Raft

  2026-04-12

  This study uncovers how cancer-associated fibroblasts (CAFs) drive oral squamous cell carcinoma (OSCC) progression by secreting fatty acids that facilitate lipid raft assembly and activate oncogenic signaling. The findings highlight a novel lipid metabolic axis between CAFs and tumor cells, with implications for targeting tumor microenvironment interactions in oral cancer.

• GSK J4 HCl: Optimizing JMJD3 Inhibition for Epigenetic Resea

  2026-04-11

  GSK J4 HCl enables precise and cell-permeable JMJD3 inhibition, empowering workflows from inflammation assays to pediatric glioma models. This guide translates cutting-edge reference findings into actionable protocols and troubleshooting strategies, maximizing reproducibility and data quality in epigenetic regulation research.

• Y-27632 Dihydrochloride: Advanced ROCK Inhibition for Cell A

  2026-04-11

  Y-27632 dihydrochloride enables precise, reproducible modulation of cytoskeletal dynamics and cell survival in demanding biological assays. Discover how this selective ROCK inhibitor empowers rapid-iteration workflows, stem cell expansion, and tumor invasion studies—with proven troubleshooting strategies for maximizing your experimental impact.

• Hexetidine (NSC-17764): Broad-Spectrum Oral Antimicrobial...

  2026-04-10

  Hexetidine (NSC-17764) is a broad-spectrum antimicrobial agent, effective as a mouthwash for dental plaque reduction and gingivitis treatment. Its utility in oral infection models is supported by reproducible in vitro and clinical benchmarks. This article delivers atomic, machine-readable evidence for its mechanism, applications, and experimental best practices.

453 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page